Microbix Biosystems Stock Forward View - Simple Regression
| MBX Stock | CAD 0.23 -0.01 -4.17% |
The successful prediction of Microbix Biosystems' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Microbix Biosystems, which may create opportunities for some arbitrage if properly timed.
As of today, the 14-period RSI for Microbix Biosystems is 0, signaling extreme oversold conditions. Readings below 20 are commonly associated with potential stabilization zones.Momentum 48
Impartial
Oversold | Overbought |
Quarterly Earnings Growth -0.95 | EPS Estimate Current Year -0.01 | EPS Estimate Next Year 0.01 | Wall Street Target Price 0.5 | Quarterly Revenue Growth -0.30 |
This view frames how Microbix Biosystems responds to recent headlines and peer activity within its market context.
The Simple Regression forecasted value of Microbix Biosystems on the next trading day is expected to be 0.23 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.46.Microbix Biosystems after-hype prediction price | CAD 0.23 |
Sentiment indicators are one input among forecasting models, technical signals, analyst estimates, earnings data, and momentum measures.
Microbix |
Microbix Biosystems Additional Predictive Modules
Most predictive techniques to examine Microbix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Microbix using various technical indicators. When you analyze Microbix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Microbix Biosystems Simple Regression Price Forecast For the 10th of March
Given 90 days horizon, the Simple Regression forecasted value of Microbix Biosystems on the next trading day is expected to be 0.23 with a mean absolute deviation of 0.01 , mean absolute percentage error of 0.000082 , and the sum of the absolute errors of 0.46 .Please note that although there have been many attempts to predict Microbix Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Microbix Biosystems' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Microbix Biosystems Stock Forecast Pattern
| Backtest Microbix Biosystems | Microbix Biosystems Price Prediction | Research Analysis |
Microbix Biosystems Forecasted Value
This next-day forecast for Microbix Biosystems uses model performance to estimate practical downside and upside boundaries rather than a single point target alone. Investors should still remember that no empirical framework consistently proves that one family of forecasting models will outperform all other approaches in live markets.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Microbix Biosystems stock data series using in forecasting. Note that when a statistical model is used to represent Microbix Biosystems stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 108.6966 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0075 |
| MAPE | Mean absolute percentage error | 0.0326 |
| SAE | Sum of the absolute errors | 0.4594 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Microbix Biosystems' price to converge to an average value over time is called mean reversion.
Microbix Biosystems After-Hype Price Density Analysis
As far as predicting the price of Microbix Biosystems at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range.
Next price density |
| Expected price to next headline |
Microbix Biosystems Estimiated After-Hype Price Volatility
In the context of predicting Microbix Biosystems' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Microbix Biosystems' historical news coverage.
Current Value
The after-hype framework applied to Microbix Biosystems assumes a 3 months review window and focuses on post-sentiment normalization rather than raw momentum. This view is most useful when investors want to compare sentiment-driven price extension with a more measured post-news scenario.
Microbix Biosystems Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Microbix Biosystems is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Microbix Biosystems backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Microbix Biosystems, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 3.36 | 0.00 | 0.01 | 7 Events | 1 Events | In 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.23 | 0.23 | 0.00 |
|
Microbix Biosystems Hype Timeline
Microbix Biosystems is now traded for 0.23on Toronto Exchange of Canada. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Microbix is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.01%. %. The volatility of related hype on Microbix Biosystems is about 388.07%, with the expected price after the next announcement by competition of 0.22. About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 1.2. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Microbix Biosystems recorded a loss per share of 0.03. The entity last dividend was issued on the 2nd of September 1999. Assuming the 90 days trading horizon the next forecasted press release will be in 7 days. Use Historical Fundamental Analysis of Microbix Biosystems to cross-verify projections for Microbix Biosystems. The view provides historical context for the projection set.Microbix Biosystems Related Hype Analysis
Having access to credible news sources related to Microbix Biosystems' direct competition is more important than ever and may enhance your ability to predict Microbix Biosystems' future price movements. Getting to know how Microbix Biosystems' peers react to changing market sentiment, related social.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| RVX | Resverlogix Corp | 0.00 | 4 per month | 3.58 | 0.05 | 10.00 | -9.09 | 26.67 | |
| BCT | Briacell Therapeutics Corp | -5.22 | 1 per month | 0.00 | -0.07 | 9.67 | -8.88 | 98.76 | |
| ROMJ | Rubicon Organics | -0.02 | 3 per month | 1.75 | 0.09 | 4.76 | -2.22 | 14.76 | |
| CWEB | Charlottes Web Holdings | 0.03 | 3 per month | 6.82 | 0.32 | 22.03 | -14.55 | 54.32 | |
| ADK | Diagnos | 0.02 | 2 per month | 0.00 | -0.01 | 6.45 | -5.41 | 15.44 | |
| LABS | Medipharm Labs Corp | -0.005 | 3 per month | 3.76 | 0.02 | 7.69 | -7.14 | 22.53 |
Other Forecasting Options for Microbix Biosystems
For every potential investor in Microbix, whether a beginner or expert, Microbix Biosystems' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better.Microbix Biosystems Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Microbix Biosystems stock to make a market-neutral strategy. Peer analysis of Microbix Biosystems could also be used in its relative valuation, which is a method of valuing Microbix Biosystems by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Microbix Biosystems Market Strength Events
Market strength indicators help investors to evaluate how Microbix Biosystems stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Microbix Biosystems shares will generate the highest return on.
| Rate Of Daily Change | 0.96 | |||
| Day Median Price | 0.23 | |||
| Day Typical Price | 0.23 | |||
| Price Action Indicator | -0.01 | |||
| Period Momentum Indicator | -0.01 | |||
| Relative Strength Index | 48.42 |
Microbix Biosystems Risk Indicators
The analysis of Microbix Biosystems' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Microbix Biosystems' investment and either accepting that risk or mitigating it.
| Mean Deviation | 2.14 | |||
| Standard Deviation | 3.3 | |||
| Variance | 10.91 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Microbix Biosystems
Coverage intensity for Microbix Biosystems matters because narrative visibility can influence sentiment, participation, and volatility around the name. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Other Macroaxis Stories
Story coverage on Macroaxis is built for readers who approach markets from different levels of experience but share the same need for disciplined investment context. Used well, these stories become part of a broader workflow built around idea generation, validation, and risk-adjusted portfolio design.
Story Categories
Currently Trending Categories
Microbix Biosystems Short Properties
Short sentiment tied to Microbix Biosystems matters because heavier bearish pressure can change how quickly future price expectations become unstable. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 139.2 M | |
| Cash And Short Term Investments | 12.1 M |
More Resources for Microbix Stock Analysis
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help frame valuation context across profits, cash flow, and enterprise value. They help compare Microbix to other measures in a consistent way.